SAT KARTAR LIFE LIMITED Share Price

NSE: SATKARTAR
|
Pharmaceuticals

₹ 130.95

-₹0.90 (-0.68%)
1D
Last updated 21 Oct, 2026, 10:15 IST

SAT KARTAR LIFE LIMITED Share Price Today

As of 21 Oct 2026, SAT KARTAR LIFE LIMITED share price is ₹130.95. The stock opened at ₹128.40, compared to its previous close of ₹131.85. During today's trading session, SAT KARTAR LIFE LIMITED share price moved in the range of ₹127.30 to ₹131.00, with an average price of ₹129.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹110.30 and a high of ₹219.80. On the performance front, SAT KARTAR LIFE LIMITED share price has declined by 28.77% over the last six months and is down 24.22% on a year-on-year basis.

₹127.30
0.68% down today
₹131.00
1D LOW
1D HIGH

SAT KARTAR LIFE LIMITED Returns Calculator

Volume
5,600
Average traded price
₹129.14
Last traded time
10:15:21 21 Oct
Last traded quantity
800
Circuit
L
H
₹125.30
₹138.40
52-week
L
H
₹110.30
₹219.80
Mkt Cap Cr
208.26
P/E
13.84
P/B
3.5
ROA
24.42%
ROE
28.72%
ROCE
37.26%
Quick Ratio
3.77
EV/EBITDA
8.01
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sat Kartar Life has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Sat Kartar Life appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Sat Kartar Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,18,683.9534.555.0111.19%13.74%17.33%2.3121.41
Divis Laboratories2,44,762.0382.514.414.6%15.32%19.56%3.554.74
Torrent Pharmaceuticals1,73,078.7980.2820.584.87%25.49%13.85%0.7537.36
Laurus Labs1,11,433.99102.221.0210.38%16.77%16.14%0.6854.47
Zydus Lifesciences1,11,022.1824.174.18.57%18.59%17.35%0.9114.94
Cipla1,07,527.5832.043.127.92%11.27%14.95%2.518.16
Dr. Reddy's Laboratories1,03,667.2932.562.725.48%11.07%12.54%1.3516.32
Mankind Pharma93,013.6244.985.717.36%11.74%13.13%0.7424.75
Aurobindo Pharma92,923.5325.042.456.34%9.25%11.76%1.1512.27
Lupin89,436.7716.093.9814.47%23.76%24.88%1.429.59

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SAT KARTAR LIFE LIMITED

ISIN
INE0NB801022
Sector Market Cap
₹ 208.26 Cr

Sat Kartar Shopping Ltd is an India-based company, which manufactures, curates, and makes available online, authentic ayurvedic products in India. The Company’s products includes Ayush Total Health, Liv Muztang Plus, Shilajit Imli Prash, Sampoorna Arogya Herbal Tea, SK Turbo Treats, Vajra 44, Liv Muztang Capsule, Herbo 365 Oil, Addiction Killer, Adivasi Hair Oil, Aadved Bhringraj Oil, Arshoqit, Herbo 365 Capsule, Piles End, Ayush 82 Aadved, Piles Stop, Kaama Gold, Liv Muztang Healthy Shots, Ayush for Women, Addiction Killer Liquid, Liver Care, Nasha Free, Nasha Nivaran, Madhu Nivarani, Ortho Veda Oil, Power Rootz SSS Formulae, Jaam e Ishq, Gaiso Mukt, Ultimate Hammer, Diabaquit, Poshan Plus, Nari Jeevan Jyoti, Stones Veda, Ayush for Men, Ayush Kavach, Sk Pilo, Extra Time, Golden Power, Vayu Shuddhi, Sandy Rx, Ayush Kwath, Aadved Slim Veda, Asthi Urja, Dhurandar Joint Pain Oil, Arokkiyam, Aadved Sleep, Dr Piles Free, and Dr Madhu Amrit.

SAT KARTAR LIFE LIMITED Financial Highlights

  • Revenue: SAT KARTAR LIFE LIMITED reported revenue of ₹203.12 crore in FY26 vs ₹163.68 crore in FY25. It showed an increase of 24.10% on a yearly basis.
  • Operating Profit: SAT KARTAR LIFE LIMITED reported an operating profit of ₹23.22 crore in FY26 vs ₹13.15 crore in FY25. It showed an increase of 76.58% on a year-on-year basis.
  • Net Profit: SAT KARTAR LIFE LIMITED reported a net profit of ₹17.10 crore in FY26 vs ₹9.82 crore in FY25. It showed an increase of 74.13% on a yearly basis.
Know more
Promoters
63.62%
FII
0.13%
Other DII
2.26%
Retail and other
34.00%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jan 20256.76%
Mar 20256.31%
Sep 20250.44%
Mar 20260.13%
1 day
-1.16%
1 week
-8.05%
1 month
-7.73%
1 year
-24.22%
3 years
-18.38%
5 years
-18.38%
Day
Open / Close
Change %
19 Oct 26
₹133.50 / ₹131.85
-1.16%
16 Oct 26
₹130.30 / ₹133.40
+0.49%
15 Oct 26
₹138.00 / ₹132.75
-4.97%
14 Oct 26
₹136.50 / ₹139.70
+2.42%
Show more

SAT KARTAR LIFE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹200.70₹162.92
Other Income₹2.42₹0.76
Total Revenue₹203.12₹163.68
Total Expenses₹179.90₹150.53
Profit Before Tax₹23.22₹13.15
Tax₹6.11₹3.34
Profit After Tax₹17.10₹9.82
EPS - Basic₹10.86₹7.37
EPS - Diluted₹10.86₹7.37

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹23.22₹13.15
Income before WC changes₹24.91₹15.31
Change in Assets-₹22.54-₹14.55
Change in Liabilities₹4.38-₹2.57
Change in WC-₹18.16-₹17.12
Cash flow from Operations₹0.48-₹5.07
Cash flow from Investing-₹8.55-₹0.31
Cash flow from Financing-₹0.77₹33.56
Total Cash Flow-₹8.84₹28.18
Cash (Start of the year)₹30.70₹2.52
Cash (End of the year)₹21.86₹30.70

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹15.41₹9.08
Current Assets₹69.45₹55.74
Total Assets₹84.85₹64.82
Current Liabilities₹15.65₹11.34
Net Current Asset₹53.80₹44.41
Non-Current Liabilities₹1.60₹1.99
Equity Capital₹67.60₹51.50
Total Equity & Liabilities₹84.85₹64.82

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹193.84₹162.92₹127.91₹82.97
Other Income₹2.42₹0.76₹0.20₹0.01
Total Revenue₹196.26₹163.68₹128.11₹82.98
Total Expenses₹172.92₹150.53₹119.52₹79.53
Profit Before Tax₹23.34₹13.15₹8.59₹3.44
Tax₹6.09₹3.34₹2.29₹0.94
Profit After Tax₹17.26₹9.82₹6.31₹2.51
EPS - Basic₹10.96₹7.37₹22.52₹3.58
EPS - Diluted₹10.96₹7.37₹22.52₹3.58

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹23.34₹13.15₹8.59₹3.44
Income before WC changes₹24.96₹15.31₹10.56₹5.26
Change in Assets-₹22.21-₹14.55-₹3.78₹0.22
Change in Liabilities₹3.57-₹2.57₹3.22₹3.18
Change in WC-₹18.64-₹17.12-₹0.56₹3.41
Cash flow from Operations₹0.14-₹5.07₹7.04₹7.97
Cash flow from Investing-₹8.68-₹0.31-₹2.61-₹3.51
Cash flow from Financing-₹0.75₹33.56-₹2.57-₹4.88
Total Cash Flow-₹9.29₹28.18₹1.86-₹0.42
Cash (Start of the year)₹30.70₹2.52₹0.65₹1.08
Cash (End of the year)₹21.41₹30.70₹2.52₹0.65

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹15.52₹9.08₹9.80₹8.28
Current Assets₹68.67₹55.74₹11.95₹6.43
Total Assets₹84.18₹64.82₹21.75₹14.71
Current Liabilities₹14.92₹11.34₹11.80₹9.01
Net Current Asset₹53.74₹44.41₹0.15-₹2.58
Non-Current Liabilities₹1.60₹1.99₹0.52₹2.42
Equity Capital₹67.66₹51.50₹9.43₹3.27
Total Equity & Liabilities₹84.18₹64.82₹21.75₹14.71
* All values are in INR Crore
Qty
Bid
800
127.65
800
127.6
800
127.5
1600
127.3
800
126.7
Ask
Qty
130.95
800
131
800
135
800
135.95
800
136
800
Bid Total: 4800
Ask Total: 4000
Buy orders: 55%
Sell orders: 45%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.24
Neutral
ATR (14)
14.33
Neutral
STOCH(9,6)
12.9
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
29.5
Bearish
UO(9)
36.78
Neutral
ROC(12)
-32.07
Bearish
WillR(14)
-93.2
Bullish
Period
Simple value
Exponential vaue
5D
134.82
135.82
10D
142.44
142.74
20D
159.57
147.8
50D
139.43
145.56
100D
142.64
146.94
Volume trend — traded volume by day
21 Oct0L
19 Oct0L
16 Oct1L
15 Oct0L
14 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SAT KARTAR LIFE LIMITED
Pharmaceuticals
Add Stock
Add Another

SAT KARTAR LIFE LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.